Compare CVS Health Corp (CVS) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? CVS Health Corp trades at $106.03 (market cap $135.12B), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $57.7. The key difference: CVS Health Corp pays a 2.51% dividend while SP Funds S&P 500 Sharia Industry Exclusions ETF pays none, and CVS Health Corp is trading nearer its 52-week high, SP Funds S&P 500 Sharia Industry Exclusions ETF nearer its low. Which is the better fit depends on your goals.
| CVS | SPUS | |
|---|---|---|
Market Cap | $135.12B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $106.18 | $59.51 |
52-Week Low | $58.75 | $45.13 |
Enterprise Value | $201.66B | — |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
SPUS trades at $57.00, down 1.35% today, with a bullish technical signal from moving averages and neutral oscillators. Recent dividend distributions of $0.03 per share occurred in April, May, and June 2026, reflecting a shareholder return focus. The stock's support and resistance levels are tightly clustered around the current price, indicating potential for near-term consolidation.
The outlook is supported by technical strength but lacks fundamental valuation metrics for deeper analysis. Risks include market volatility and dependence on broader equity trends. Investor sentiment appears neutral, with institutional interest noted from recent filings, though analyst consensus data is unavailable.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
